Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9600
Title: Sub Chronic Toxicity Study of Coumacines
Authors: Al-Shakarchi, Wejdan
Saber, Yasir
M. Merkhan, Marwan
Fakri Mustafa, Yasser
Keywords: Coumacine, Hepatotoxicity, Bleeding, Clotting
Issue Date: 2022
Abstract: Coumacine is a brand-new heterocyclic molecular nucleus that was discovered in 2018. In addition to the unique heterocycle known as coumacine, the designer has developed two variants known as coumacine I and II. Coumacine derivatives had been evaluated for their antibacterial effects in vitro against a variety of aerobic and anaerobic bacteria using conventional bacterial strains, using ciprofloxacin and metronidazole as positive controls. The purpose of this research is to look into the relationship between the anticoagulant activity and hepatotoxicity of coumarin and coumacine because the former is a synthetic precursor of the latter and many natural and synthetic coumarins involving warfarin have anticoagulant activity. Thirty male mice were used in this study and exposed to a subchronic dose of 250 or 500 mg/kg of coumacine I or coumacine II. The results of histochemistry showed dramatic changes in hepatocellular morphology that were dose-dependent for both coumacine I and II. Traditionally, higher doses of Coumacine I and II resulted in a significant increase in liver enzymes. Coumacine I or II did no effect on bleeding time. In conclusion, coumacines at subchronic high doses might have hepatotoxic effects through a mechanism that does not affect the coagulation process. Key words: Coumacine, Hepatotoxicity, Bleeding, Clotting
URI: http://localhost:8080/xmlui/handle/123456789/9600
Appears in Collections:VOL 15 NO 1 2023

Files in This Item:
File Description SizeFormat 
21.pdf1.55 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.